# Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

> **NCT04229537** · PHASE1 · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** SCT-I10A
- **BIOLOGICAL:** SCT200
- **OTHER:** Chemotherapy

## Key facts

- **NCT ID:** NCT04229537
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04229537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04229537, "Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04229537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*